Toggle navigation
Home
Search
Services
Blog
Contact
About
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David James
Virginia Commonwealth University, Richmond, VA, United States
Search 4 grants from David Mokler
Search grants from Virginia Commonwealth University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Understanding the prefrontal mechanisms involved in the enhancement and maintenance of visual signals
Role of Staphylococcus aureus alpha-hemolysin in disease
B1 cell-mediated immunity in Human Immune System mice
State Implementation Projects for Preventing Secondary Conditions
AIDS Infrastructure - Alteration and Renovation
Recently added grants:
Proteomic Biomarkers for Glaucomatous Optic Neuropathy
Molecular Mechanisms of Photoreceptor Adaptation
Top-Down Proteomics of Myofilaments in Heart Failure
Molecular characterization of cardiomyopathy mutations in human cardiac myosin
Breaking a novel feedback loop to inhibit fibrosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DA005260-02
Application #
3035089
Study Section
(DABA)
Project Start
1986-07-01
Project End
Budget Start
1986-07-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Related projects
NIH 1986
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
NIH 1985
F32 DA
5-Hydroxtrytamine Sites of Hallucinogen Drug Action
Mokler, David J. / Virginia Commonwealth University
Publications
Mokler, D J; Robinson, S E; Rosecrans, J A
(1987)
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Eur J Pharmacol 138:265-8
Comments
Be the first to comment on David Mokler's grant